Anthracimycin

Anthracimycin is an aminoacyl-tRNA synthetase inhibitor. Anthracimycin exhibits in vitro antibacterial activity against methicillin-resistant Staphylococcus aureus strains, Bacillus anthracis, and Mycobacterium tuberculosis. Anthracimycin can be used in antibacterial research[1].

Product Specifications

CAS Number

[1452849-94-3]

UNSPSC

12352005

Target

Bacterial

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Smiles

[H][C@@]1([C@@H](C)/C=C\C=C\[C@@H](C)OC2=O)[C@@](C(CC([C@H]2C)=O)=O)([H])[C@]3([H])[C@]([H])(CC(C)=CC3)C=C1

Molecular Formula

C25H32O4

Molecular Weight

396.52

References & Citations

[1]Tian P, et al. Ten-step asymmetric total syntheses of potent antibiotics anthracimycin and anthracimycin B. Chem Sci. 2022 Oct 15;13 (43) :12776-12781.